Search Results

You are looking at 21 - 30 of 33 items for :

  • "intensive therapy" x
  • All content x
Clear All
Orvosi Hetilap
Authors: Judit Hallay, Dániel Nagy, and Béla Fülesdi

://www.weborvos.hu/egeszsegmagazin/felmertek_a_korhazi_betegek_taplaltsagi/195271/ [Hungarian] Bogár, L.: Anesthesia and intensive therapy. [Aneszteziológia és intenzív terápia.] Medicina Könyvkiadó, Budapest, 2009. [Hungarian] Weijs, P. J., Stapel, S

Restricted access
Orvosi Hetilap
Authors: Anna Selmeczi, Miklós Udvardy, Árpád Illés, Béla Telek, Attila Kiss, Péter Batár, Gyula Reményi, Róbert Szász, Zsófia Ujj, Adrienn Márton, Anikó Újfalusi, Zsuzsanna Hevessy, László Pinczés, Judit Bedekovics, and László Rejtő

., et al.: Phase II study of bortezomib as a single agent in patients with previously untreated or relapsed/refractory acute myeloid leukemia ineligible for intensive therapy. Leuk. Res. Treatment, 2013, 2013, 705–714.

Restricted access

a trial of intensive therapy. N Engl J Med. 2000; 342: 381–389. 16 Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and

Restricted access

skills training as adjunct to intensive therapy in adolescents. Diabetes Care 21, 902–908 (1998) Tamborlane W.V. Short-term effects of coping skills training as adjunct to intensive therapy in adolescents Diabetes Care

Restricted access
Orvosi Hetilap
Authors: Nikolett Jusztina Beniczky, Éva Hosszú, Dániel János Erdélyi, Judit Müller, Zsuzsanna Jakab, and Gábor Kovács

–263. 16 Padhye B, Dalla-Pozza L, Little D, et al. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL). Cancer Med. 2016

Open access
Orvosi Hetilap
Authors: Cecília Czakó, Gábor László Sándor, Mónika Ecsedy, Zsuzsanna Szepessy, Ágnes Borbándy, Miklós Resch, András Papp, Zsuzsa Récsán, Hajnalka Horváth, Zoltán Zsolt Nagy, and Illés Kovács

nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000; 342: 381–389. 10 Holman R, Paul S, Bethel M, et al. Long-term follow-up after tight

Open access
Orvosi Hetilap
Authors: Béla Telek, László Rejtő, Péter Batár, Zsófia Miltényi, Gyula Reményi, Zsófia Simon, Zsófia Ujj, Gabriella Mezei, Róbert Szász, Attila Kiss, Miklós Udvardy, and Árpád Illés

. P.: Finding the optimal combination therapy for the treatment of newly diagnosed AML in older patients unfit for intensive therapy. Leuk. Res., 2015, 39 (2), 183–191. 30

Restricted access
Interventional Medicine and Applied Science
Authors: Olexandr Smiyan, Mykola Lyndin, Oksana Romaniuk, Vladyslav Sikora, Artem Piddubnyi, Alla Yurchenko, Anna Korobchanska, Iryna Tarasova, Natalia Hyryavenko, Kateryna Sikora, and Anatolii Romaniuk

(15 mg/kg/day). Despite the conducted treatment, the multiple organ failure syndrome developed on the second day of intensive therapy (day 14 of life) that caused the death of the child. During the postmortem examination , the

Open access

Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary. The study population included all patients treated in the 12-bed multidisciplinary ICU during the given time period without considering the patients’ diagnosis. We

Open access
Acta Microbiologica et Immunologica Hungarica
Authors: Balazs Ittzes, Eva Szentkiralyi, Zoltan Szabo, Istvan Z. Batai, Ors Gyorffy, Tamas Kovacs, Istvan Batai, and Monika Kerenyi

amiodarone with sodium bicarbonate, heparin, sugammadex, meropenem and vaborbactam, and total parenteral nutrient solutions [ 29–33 ]. Glyceryl trinitrate is another medication that was used in cardiology and intensive therapy. We reported in 1999 that it had

Open access